About Us
Contact Us
Regulatory
Community
Site Map
Links
Stock Price
Glossary
Investor Relations
Media Gateway
Businesses
Governance
Uranium 101
Careers
News Releases Factsheets & Publications Images Features Nuclear News Contact Us
Related Information
Cameco MS Neuroscience Center Launches New Campaign
Print Page
Print Page

Cameco MS Neuroscience Center Launches New Campaign

Saskatoon, Saskatchewan, Canada, September 20, 2000

The Cameco MS Neuroscience Research Center announced today it is building on the success of the Cameco Quest for a Cure by launching a new province-wide fundraising campaign called The Quest Continues.

The goal of the new campaign is to raise $600,000 to expand the Center, which conducts research into Multiple Sclerosis and other neurological disorders.

Cameco Corporation, which generously sponsored the original Quest for a Cure in 1994-95, is donating all campaign costs for The Quest Continues.

"Cameco is renewing our investment because we strongly believe that research is an investment that always leads to success. Scientists at the Center will find effective treatments – not only for MS, but for disorders such as Alzheimer's, Parkinson's and Lou Gehrig's disease," says Bernard Michel, Cameco's Chair and CEO.

 "Cameco's support is a tremendous boost," says Dr. David Schreyer, Director of the Research Center. "It allows 100% of every donation to go directly to the Research Center. We're very grateful for their support."

"The fact that Saskatchewan has the highest incidence of Multiple Sclerosis in Canada was the motivating force behind establishing the Center. When it opened in 1996, it was Saskatchewan's first and only MS research facility – it still is, and work being done here is giving hope to people who live with this disease," says Dr. Hader, Honorary Chair for Northern Saskatchewan.

Hader had been a leader in the fight against MS in Saskatchewan for more than 30 years and is Director of the MS Clinic in Saskatoon. "In four years, the Center has matured into a nationally recognized facility. Our priority now is to expand so we can attract more research dollars to Saskatchewan."

MS is a disease of the central nervous system that can affect vision, balance, the ability to walk and talk, and more. It strikes primarily young adults between the ages of 20 and 40, and women are twice as likely to develop it as men.

Actual research at the Center is funded by external granting agencies. According to Dr. Schreyer, "each scientist wins funding for his or her own research in national and international competitions. To date, our team has won more than $3.4 million in external research grants.

"If the grants continue at this pace," Schreyer says, "by the end of the first ten years, the $1.6 million raised by the people of Saskatchewan will have been matched sixfold by the scientists themselves. I think that shows what a superb investment the Center has been.

"By making room for new scientists, we will increase research activity and attract more research dollars. Also, this Center is unique in its emphasis on interaction between research scientists and clinical specialists working with patients, and we hope the expansion will attract more clinical scientists," Schreyer says.

The Quest Continues began its fund-raising drive in the black thanks to more than $10,000 raised by the first ever 100 Holes of Golf tournament held August 29 at the Moonlake Golf and Country Club. The event was sponsored by CJWW Radio. Proceeds from the upcoming No Show Marathon will also go to the Quest. Organizers are hoping Saskatchewan people step forward with their donations to ensure The Quest Continues well into the new millennium.

For information, contact:

Dr. Walter Hader
Honorary Chair
Northern Saskatchewan
655-8447

 

Dr. David Schreyer
Director,
Cameco MS Neuroscience Research Center
655-8711

Or visit our web site at www.usask.ca/healthsci/cmsnrc/main/quest.htm

The Facts About ... Multiple Sclerosis

The Facts About ... The Cameco MS Neuroscience Research Center